Search
Search Results
##search.searchResults.foundPlural##
-
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3451PDF: 1187HTML: 458 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2518PDF: 802HTML: 1742 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
1082PDF: 644HTML: 426 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4375PDF: 1401HTML: 2065 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2685PDF: 763HTML: 2320 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2922PDF: 872HTML: 6538Untitled: 250Untitled: 203Untitled: 224Untitled: 231 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1842PDF: 1188HTML: 258 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1801PDF: 839HTML: 183 -
THE CHALLENGE OF AML IN OLDER PATIENTS
2220PDF: 999HTML: 2176 -
-
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1214PDF: 775HTML: 1496Figure 1: 196Figure 2: 199 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2217PDF: 851HTML: 938Patient’s family tree: 184 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1498PDF: 922Suppl. Files: 462HTML: 248 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3716PDF: 913HTML: 6729 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2797PDF: 916HTML: 238 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1212PDF: 847HTML: 2190Figue 1: 182 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2162PDF: 1561HTML: 538 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1337PDF: 1113PDF: 906HTML: 189 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1138PDF: 455HTML: 254 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1088PDF: 1196Suppl. Files: 575HTML: 94 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1550PDF: 1099HTML: 226 -
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia
1680PDF: 527HTML: 170 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4983PDF: 1334HTML: 1924Untitled: 190Untitled: 186 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3249PDF: 986HTML: 3140flowcytometric result of peripheral blood sample: 187







